Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 7211.07 | nM | 19496609 | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 377.57 | nM | 25554367 | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 12331.05 | nM | 19969457 | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 120.78 | nM | PubChem BioAssay data set | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 12764.39 | nM | 8984161 | |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | 822.24 | nM | 17132069 | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 959.4 | nM | Open TG-GATES in vivo data: Hematology | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 391.74 | nM | 10.6019/CHEMBL1201861 | |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | 959.4 | nM | 10.6019/CHEMBL1201861 | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 790.68 | nM | 16378381 | |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | 3176.87 | nM | 16933872 | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 1462.18 | nM | 20719504 | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 1273.5 | nM | 18715034 | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 2065.38 | nM | 19215141 | |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 1967.89 | nM | 12542359 | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 1807.17 | nM | 19576785 | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 60.67 | nM | DrugMatrix in vitro pharmacology data | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 9571.94 | nM | 9548875 | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 147.23 | nM | 16872131 | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 783.43 | nM | 23675651 | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 1489.36 | nM | 14643343 | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 15452.54 | nM | 17512094 | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 14354.89 | nM | 1517742 | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 3639.15 | nM | 18183025 | |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | 1294.2 | nM | PubChem BioAssay data set | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 17701.09 | nM | 15270558 | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 420.73 | nM | 19271765 | |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | 610.94 | nM | 21561780 | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 1559.55 | nM | 10649969 | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 515.23 | nM | 12444692 | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 2123.24 | nM | 18788725 | |
NPT2752 | Individual Protein | DNA (cytosine-5)-methyltransferase 1 | Homo sapiens | Activity | = | 1.25 | nM | 18227183 |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 337.29 | nM | 19075048 | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 1013.91 | nM | 24183741 | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 11402.5 | nM | 11784156 | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 1458.81 | nM | 1517739 | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 2013.72 | nM | 9871756 | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 448.75 | nM | DrugMatrix in vitro pharmacology data | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 916.22 | nM | 15646539 | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 1836.54 | nM | 20025236 | |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | 1592.21 | nM | 21539301 | |
NPT3804 | Cell Line | Human Tumor Cell lines | GI50 | = | 676 | nM | 10377223 | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 954.99 | nM | PubChem BioAssay data set | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 15667.51 | nM | 24900585 | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 16982.44 | nM | 20028029 | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 3191.54 | nM | 23350733 | |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | 1158.78 | nM | 11170658 | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 230.14 | nM | 11325244 | |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | 1694.34 | nM | 8984155 | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 181.13 | nM | 10.1007/s00044-011-9767-1 | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 1503.14 | nM | 8864237 | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 11455.13 | nM | PubChem BioAssay data set | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 1016.25 | nM | 21084196 | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 1725.84 | nM | 17896816 | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 6668.07 | nM | 19848433 | |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | 319.15 | nM | 17958396 | |
NPT3804 | Cell Line | Human Tumor Cell lines | TGI | = | 3020 | nM | 19738026 | |
NPT3804 | Cell Line | Human Tumor Cell lines | LC50 | = | 11500 | nM | 19738026 | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 1399.59 | nM | 18591275 | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 562.34 | nM | 21440339 | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | 1101.54 | nM | 15974609 | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 926.83 | nM | 17958396 | |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 3228.49 | nM | 17958396 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC51086 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9487 | High Similarity | NPC180409 |
0.9 | High Similarity | NPC474773 |
0.9 | High Similarity | NPC160588 |
0.878 | High Similarity | NPC99746 |
0.8293 | Intermediate Similarity | NPC107849 |
0.7805 | Intermediate Similarity | NPC55269 |
0.7442 | Intermediate Similarity | NPC259702 |
0.6977 | Remote Similarity | NPC101811 |
0.68 | Remote Similarity | NPC469971 |
0.6667 | Remote Similarity | NPC469969 |
0.6545 | Remote Similarity | NPC183031 |
0.6481 | Remote Similarity | NPC469962 |
0.6136 | Remote Similarity | NPC201753 |
0.6102 | Remote Similarity | NPC52966 |
0.5932 | Remote Similarity | NPC110214 |
0.5893 | Remote Similarity | NPC469967 |
0.56 | Remote Similarity | NPC473533 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC51086 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
NPD |
PubChem CID   | 132430 |
ChEMBL   | CHEMBL136685 |
ZINC   |
Molecular Weight:   | 397.86 |
ALogP:   | 4.5804 |
MLogP:   | 2.01 |
XLogP:   | 5.538 |
# Rotatable Bonds:   | 13 |
Polar Surface Area:   | 0 |
# H-Bond Aceptor:   | 0 |
# H-Bond Donor:   | 0 |
# Rings:   | 0 |
# Heavy Atoms:   | 15 |